Discover Who Is Attending the 3rd Annual Personalized Cancer Vaccine Summit 2026
Discover the companies joining the 3rd Annual Personalized Cancer Vaccine Summit 2026. Featuring organizations represented by our speakers and delegates, this page reflects the diverse community of leaders, innovators, and decision-makers attending this year's event.
Attending Companies Include
AIVITA Biomedical
AngenMed Therapeutics
BioNTech
CellVax Therapeutics
City of Hope Comprehensive Cancer Center
Diakonos Oncology
Echo Immune
Elios Therapeutics
Genentech
Geneos Therapeutics
HDT Bio
Mayo Clinic
Medici Therapeutics
Merck & Co
Moderna
NEC Bio
Nykode Therapeutics
Parker Institute for Cancer Immunotherapy
Purdue University
SeqCure Immunology
Syncromune
The University of Texas MD Anderson Cancer Center
Transgene
YGION Biomedical
Explore the Agenda
Discover the latest breakthroughs shaping personalized cancer vaccine development, from novel target selection strategies, innovative vaccine modalities to clinical and commercial insights. Gain exclusive insights from industry leaders during data-driven presentations, interactive workshops, and expert panel discussions.
Partner With Us
Showcase your solutions alongside other leading service providers to a community dedicated to cutting-edge individualized therapy innovation. Position your brand at the heart of the biopharma deals and partnerships defining oncology immunotherapies.
Join Cancer Vaccine Experts
Connect with cancer vaccine innovators and engage in the hottest conversations propelling safe, efficacious and commercially viable vaccine development. During the dedicated networking sessions, make critical connections, and build meaningful collaborations.